A vs AKTX: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Akari Therapeutics Plc in 2026
A
Agilent Technologies Inc
$118.25
AKTX
Akari Therapeutics Plc
$5.12
Key Metrics Comparison
| Metric | A | AKTX | Winner |
|---|---|---|---|
| Market Cap | $33.88B | $5.28M | A |
| P/E Ratio | 26.62 | N/A | A |
| EPS (TTM) | $4.50 | $N/A | A |
| Revenue Growth | 0.1% | 0.0% | A |
| Gross Margin | 52.3% | 0.0% | A |
Analyze A
Full quant analysis
Analyze AKTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or AKTX a better investment?
Comparing A and AKTX: Agilent Technologies Inc has a market cap of $33.88B while Akari Therapeutics Plc has $5.28M. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and AKTX?
A (Agilent Technologies Inc) and AKTX (Akari Therapeutics Plc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or AKTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: A or AKTX?
A has higher revenue growth at 0.1% vs 0.0% for AKTX.
Which company is more profitable: A or AKTX?
Agilent Technologies Inc (A) has higher gross margins at 52.3% compared to 0.0% for AKTX.
Which is the larger company: A or AKTX?
Agilent Technologies Inc (A) is larger with a market cap of $33.88B compared to $5.28M for AKTX.
Should I buy A or AKTX in 2026?
Both A and AKTX have investment merit. A trades at $118.25 while AKTX trades at $5.12. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and AKTX stock?
Key differences: Market Cap ($33.88B vs $5.28M), P/E Ratio (26.6x vs N/A), Revenue Growth (0.1% vs 0.0%), Gross Margin (52.3% vs 0.0%).